In addition to the results, Roche also announced that the US Food and Drug Administration (FDA) has accepted the company’s ...
Liza M. Cohen, MD, explains when to use CT vs MRI in thyroid eye disease and why to review images yourself.
Koreishi, MD, explains why inflammation control and planning are key to cataract surgery for patients with uveitis.
Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months.
The US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to ...
Keith Warren, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...
Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...
Talley Rostov is a partner at Northwest Eye Surgeons in Seattle, Washington, and serves as a board member and medical liaison for SightLife. She is a consultant for Glaukos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results